Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2019-08-10 2019-08-09
Drug Identification Number 02414120 02414120
Brand name RAN-OLANZAPINE ODT RAN-OLANZAPINE ODT
Common or Proper name RAN-OLANZAPINE ODT RAN-OLANZAPINE ODT
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 28 28
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-09 2019-08-09
Remaining supply date 2019-08-09 2019-08-09
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments